• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺血性肾病与伴发的主动脉疾病:十年经验

Ischemic nephropathy and concomitant aortic disease: a ten-year experience.

作者信息

Chaikof E L, Smith R B, Salam A A, Dodson T F, Lumsden A B, Kosinski A S, Coyle K A, Allen R C

机构信息

Joseph B. Whitehead Department of Surgery, Emory University School of Medicine, Atlanta, GA.

出版信息

J Vasc Surg. 1994 Jan;19(1):135-46; discussion 146-8. doi: 10.1016/s0741-5214(94)70128-8.

DOI:10.1016/s0741-5214(94)70128-8
PMID:8301725
Abstract

PURPOSE

The durability of renal preservation after surgical intervention has not been well defined, particularly in patients with associated aortic disease. A review of all patients at the Emory University Hospital with renal insufficiency (creatinine level > or = 1.8) and concomitant atherosclerotic aortic and renovascular disease was undertaken.

METHODS

Fifty patients underwent both renal revascularization (71 kidneys) and the repair of aneurysmal or symptomatic aortic occlusive disease between 1982 and 1992. Hypertension was present in 96% of patients and diabetes was present in 10%. The preoperative estimated glomerular filtration rate (EGFR) was 25.18 +/- 8.29 ml/min (creatinine level 3.1 +/- 1.5 mg/dl). Operative management included bilateral renal artery repair (n = 21), unilateral repair alone (n = 17), and unilateral repair with contralateral nephrectomy (n = 12). The relative percent change in the postoperative EGFR (> or = 7 days after operation) increased by at least 20% in 42% of the patients, had decreased by 20% or more in only 4%, and was otherwise categorized as unchanged in the remaining 54% of the study group.

RESULTS

The 30-day operative mortality rate was 2.0% (1 of 50). Forty-five of the surviving 49 patients (91.8%) were available for follow-up (median 49 months). During this period nine patients (18.4%) eventually required dialysis, four within 6 months of operation, and 19 patients died. Neither subgroup experienced a retrieval of renal function after operation. Five-year survival rate was 61%, and a trend was noted between the risk of death and the relative change in EGFR after operation (p = 0.13). The likelihood of eventually requiring long-term dialysis was highest among those patients with low preoperative functional renal reserve as measured by preoperative creatinine level of 3 mg/dl or greater (p < 0.0001), or preoperative EGFR less than 20 ml/min (p = 0.0001). Blood pressure was cured or improved in 50% at late follow-up.

CONCLUSIONS

Early improvement of renal function may be observed in nearly one half of patients subjected to combined aortic and renal revascularization. Nonetheless, renal preservation may not be sustainable in patients with compromised preoperative function. Intervention before marked functional decline remains the best option for minimizing the risk of eventual dialysis.

摘要

目的

手术干预后肾脏保存的耐久性尚未明确界定,尤其是在伴有主动脉疾病的患者中。我们对埃默里大学医院所有肾功能不全(肌酐水平≥1.8)且伴有动脉粥样硬化性主动脉和肾血管疾病的患者进行了回顾性研究。

方法

1982年至1992年间,50例患者同时接受了肾血管重建术(71个肾脏)以及动脉瘤或有症状的主动脉闭塞性疾病修复术。96%的患者患有高血压,10%的患者患有糖尿病。术前估计肾小球滤过率(EGFR)为25.18±8.29 ml/分钟(肌酐水平3.1±1.5 mg/dl)。手术管理包括双侧肾动脉修复(n = 21)、单纯单侧修复(n = 17)以及单侧修复加对侧肾切除术(n = 12)。术后EGFR(术后≥7天)相对百分比变化至少增加20%的患者占42%,降低20%或更多的仅占4%,其余54%的研究组患者变化归类为无变化。

结果

30天手术死亡率为2.0%(50例中的1例)。49例存活患者中有45例(91.8%)可供随访(中位随访时间49个月)。在此期间,9例患者(18.4%)最终需要透析,4例在术后6个月内需要透析,19例患者死亡。两个亚组术后均未出现肾功能恢复。5年生存率为61%,并且观察到术后死亡风险与EGFR相对变化之间存在趋势(p = 0.13)。术前肌酐水平≥3 mg/dl或术前EGFR<20 ml/分钟所测量的术前功能性肾储备低的患者中,最终需要长期透析的可能性最高(p<0.0001),或术前EGFR<20 ml/分钟(p = 0.0001)。在后期随访中,50%的患者血压得到治愈或改善。

结论

在接受主动脉和肾血管联合重建术的患者中,近一半患者可能会观察到肾功能早期改善。尽管如此,术前功能受损的患者肾脏保存可能无法持续。在明显功能下降之前进行干预仍然是将最终透析风险降至最低的最佳选择。

相似文献

1
Ischemic nephropathy and concomitant aortic disease: a ten-year experience.缺血性肾病与伴发的主动脉疾病:十年经验
J Vasc Surg. 1994 Jan;19(1):135-46; discussion 146-8. doi: 10.1016/s0741-5214(94)70128-8.
2
Surgical management of atherosclerotic renovascular disease.动脉粥样硬化性肾血管疾病的外科治疗
J Vasc Surg. 2002 Feb;35(2):236-45. doi: 10.1067/mva.2002.120376.
3
Surgery after failed percutaneous renal artery angioplasty.经皮肾动脉血管成形术失败后的手术治疗。
J Vasc Surg. 1999 Sep;30(3):468-82. doi: 10.1016/s0741-5214(99)70074-1.
4
Management of ischemic nephropathy: dialysis-free survival after surgical repair.缺血性肾病的管理:手术修复后的无透析生存期
J Vasc Surg. 2000 Sep;32(3):472-81; discussion 481-2. doi: 10.1067/mva.2000.108637.
5
Surgical management of dialysis-dependent ischemic nephropathy.
J Vasc Surg. 1995 Feb;21(2):197-209; discussion 209-11. doi: 10.1016/s0741-5214(95)70262-8.
6
Empirical reconstruction of the renal artery: long-term outcome.肾动脉的经验性重建:长期结果
J Vasc Surg. 1996 Sep;24(3):406-14. doi: 10.1016/s0741-5214(96)70196-9.
7
Concomitant aortic and renal artery reconstruction in patients on an intensive antihypertensive medical regimen: long-term outcome.
Ann Vasc Surg. 1998 May;12(3):270-7. doi: 10.1007/s100169900152.
8
Is renal revascularization in diabetic patients worthwhile?糖尿病患者的肾脏血管重建是否值得?
J Vasc Surg. 1996 Sep;24(3):383-92; discussion 392-3. doi: 10.1016/s0741-5214(96)70194-5.
9
Long-term outcome of surgical revascularization in ischemic nephropathy: normalization of average decline in renal function.
J Vasc Surg. 1999 Jun;29(6):1037-49. doi: 10.1016/s0741-5214(99)70245-4.
10
Advanced renovascular hypertension and renal insufficiency: trends in medical comorbidity and surgical approach from 1970 to 1993.
J Vasc Surg. 1995 May;21(5):750-9; discussion 759-60. doi: 10.1016/s0741-5214(05)80006-0.

引用本文的文献

1
Renovascular hypertension: screening and modern management.肾血管性高血压:筛查与现代管理。
Eur Heart J. 2011 Jul;32(13):1590-8. doi: 10.1093/eurheartj/ehq510. Epub 2011 Jan 27.
2
Atherosclerotic Renal Artery Stenosis.动脉粥样硬化性肾动脉狭窄
Curr Treat Options Cardiovasc Med. 2003 Apr;5(2):91-101. doi: 10.1007/s11936-003-0017-9.
3
Renovascular disease: the fifth frontier.肾血管疾病:第五个前沿领域。
J R Soc Med. 1997 Jun;90(6):315-8. doi: 10.1177/014107689709000606.